According to filings with the U.S. Securities and Exchange Commission, TMRW Life Sciences is raising up to $28,200,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Louis Villalba played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About TMRW Life Sciences
TMRW Life Sciences is a fertility technology company that provides safety and transparency to modernize and transform egg and embryo storage. The current system is manual, outdated, and stressful for embryologists and clinicians. Automatization and state-of-the-art technology identify, track and remotely monitor frozen eggs and embryos. TMRW is a scalable solution for overcrowded clinics that have unintentionally become storage facilities since the rise in people seeking fertility treatments. Named Fast Companys #1 Most Innovative Biotech Company in 2022, TMRW is in leading clinics across the US and will soon be available in the UK and Europe.

To learn more about TMRW Life Sciences, visit http://tmrwlifesciences.com/
TMRW Life Sciences Linkedin Page: https://www.linkedin.com/company/tmrw-life-sciences-inc/

Contact:
Louis Villalba, Chief Executive Officer
917-525-3453

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.